Please assess the completion status of the following clinical trial:

Trial Title: Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults living in Riyadh area with impaired fasting glucose or/and impaired glucose tolerance (prediabetics) and total 25 OH vitamin D level between 10-30 nmol/l~* Who consume no more than one serving of milk/day~* Do not take vitamin supplement~* Habitually have less than 10 hour of sun exposure per week~* Don't suffer from granulomatus conditions, liver disease, kidney disease, or diabetes~* Don't take anticonvulsants, barbiturates, steroids, or antidiabetic medications.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Vitamin D3 (Type: EXPERIMENTAL): Vitamin D3 5000 IU daily
- Placebo (Type: PLACEBO_COMPARATOR): Placebo daily

Based on this trial design, predict the completion outcome and termination type (if applicable).